Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-10-31 4:02 pm Purchase | 13D | TAYSHA GENE THERAPIES INC TSHA | Audentes Therapeutics Inc. BOLD | 7,266,342 11.600% | 7,266,342 (New Position) | View |
| 2020-02-14 4:25 pm Sale | 13G | Audentes Therapeutics Inc. BOLD | Redmile Group LLC | 639,095 1.400% | -1,662,572 (-72.23%) | View |
| 2020-02-14 4:20 pm Sale | 13G | Audentes Therapeutics Inc. BOLD | GREAT POINT PARTNERS LLC | 0 0.000% | -2,325,000 (Position Closed) | View |
| 2020-02-14 4:05 pm Sale | 13G | Audentes Therapeutics Inc. BOLD | PFM Health Sciences LP | 1,250,668 2.700% | -1,793,817 (-58.92%) | View |
| 2020-02-11 4:39 pm Purchase | 13G | Audentes Therapeutics Inc. BOLD | VANGUARD GROUP INC | 3,225,613 7.030% | 3,225,613 (New Position) | View |
| 2020-02-05 11:25 am Purchase | 13G | Audentes Therapeutics Inc. BOLD | BlackRock Inc. BLK | 3,678,864 8.000% | 704,273 (+23.68%) | View |
| 2020-01-07 10:17 am Sale | 13G | Audentes Therapeutics Inc. BOLD | WELLINGTON MANAGEMENT GROUP LLP | 622,011 1.360% | -2,759,059 (-81.60%) | View |